|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baskar R, Yap SP, Chua KL and Itahana K:
The diverse and complex roles of radiation on cancer treatment:
Therapeutic target and genome maintenance. Am J Cancer Res.
2:372–382. 2012.PubMed/NCBI
|
|
3
|
Collins KK, Liu Y, Schootman M, Aft R, Yan
Y, Dean G, Eilers M and Jeffe DB: Effects of breast cancer surgery
and surgical side effects on body image over time. Breast Cancer
Res Treat. 126:167–176. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rastegar F, Shenaq D, Huang J, Zhang W,
Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, et al: Mesenchymal
stem cells: Molecular characteristics and clinical applications.
World J Stem Cells. 2:67–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Egeblad M, Nakasone ES and Werb Z: Tumors
as organs: Complex tissues that interface with the entire organism.
Dev Cell. 18:884–901. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kucerova L, Skolekova S, Matuskova M,
Bohac M and Kozovska Z: Altered features and increased
chemosensitivity of human breast cancer cells mediated by adipose
tissue-derived mesenchymal stromal cells. BMC Cancer. 13:5352013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ahn J, Lee HW, Seo KW, Kang SK, Ra JC and
Youn HY: Anti-tumor effect of adipose tissue derived-mesenchymal
stem cells expressing interferon-β and treatment with cisplatin in
a xenograft mouse model for canine melanoma. PLoS One.
8:e748972013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee RH, Yoon N, Reneau JC and Prockop DJ:
Preactivation of human MSCs with TNF-α enhances tumor-suppressive
activity. Cell stem cell. 11:825–835. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Di GH, Jiang S, Li FQ, Sun JZ, Wu CT, Hu X
and Duan HF: Human umbilical cord mesenchymal stromal cells
mitigate chemotherapy-associated tissue injury in a pre-clinical
mouse model. Cytotherapy. 14:412–422. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jung Y, Kim JK, Shiozawa Y, Wang J, Mishra
A, Joseph J, Berry JE, McGee S, Lee E, Sun H, et al: Recruitment of
mesenchymal stem cells into prostate tumours promotes metastasis.
Nat Commun. 4:17952013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Han ZP, Zhang SS, Jing YY, Bu XX,
Wang CY, Sun K, Jiang GC, Zhao X, Li R, et al: Effects of
inflammatory factors on mesenchymal stem cells and their role in
the promotion of tumor angiogenesis in colon cancer. J Biol Chem.
286:25007–25015. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsai KS, Yang SH, Lei YP, Tsai CC, Chen
HW, Hsu CY, Chen LL, Wang HW, Miller SA, Chiou SH, et al:
Mesenchymal stem cells promote formation of colorectal tumors in
mice. Gastroenterology. 141:1046–1056. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Klopp AH, Gupta A, Spaeth E, Andreeff M
and Marini F III: Concise review: Dissecting a discrepancy in the
literature: Do mesenchymal stem cells support or suppress tumor
growth? Stem Cells. 29:11–19. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pan F and Hong LQ: Insulin promotes
proliferation and migration of breast cancer cells through the
extracellular regulated kinase pathway. Asian Pac J Cancer Prev.
15:6349–6352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gallagher EJ, Alikhani N, Tobin-Hess A,
Blank J, Buffin NJ, Zelenko Z, Tennagels N, Werner U and LeRoith D:
Insulin receptor phosphorylation by endogenous insulin or the
insulin analog AspB10 promotes mammary tumor growth independent of
the IGF-I receptor. Diabetes. 62:3553–3560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morrison MM, Hutchinson K, Williams MM,
Stanford JC, Balko JM, Young C, Kuba MG, Sánchez V, Williams AJ,
Hicks DJ, et al: ErbB3 downregulation enhances luminal breast tumor
response to antiestrogens. J Clin Invest. 123:4329–4343. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sheng Q, Liu X, Fleming E, Yuan K, Piao H,
Chen J, Moustafa Z, Thomas RK, Greulich H, Schinzel A, et al: An
activated ErbB3/NRG1 autocrine loop supports in vivo proliferation
in ovarian cancer cells. Cancer Cell. 17:298–310. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gala K and Chandarlapaty S: Molecular
pathways: HER3 targeted therapy. Clin Cancer Res. 20:1410–1416.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sithanandam G, Smith GT, Masuda A,
Takahashi T, Anderson LM and Fornwald LW: Cell cycle activation in
lung adenocarcinoma cells by the ErbB3/phosphatidylinositol
3-kinase/Akt pathway. Carcinogenesis. 24:1581–1592. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma J, Lyu H, Huang J and Liu B: Targeting
of erbB3 receptor to overcome resistance in cancer treatment. Mol
Cancer. 13:1052014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Greco SJ and Rameshwar P: Mesenchymal stem
cells in drug/gene delivery: Implications for cell therapy. Ther
Deliv. 3:997–1004. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu W, Huang L, Li Y, Qian H, Shan X, Yan
Y, Mao F, Wu X and Xu WR: Mesenchymal stem cell-secreted soluble
signaling molecules potentiate tumor growth. Cell Cycle.
10:3198–3207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
De Boeck A, Pauwels P, Hensen K, Rummens
JL, Westbroek W, Hendrix A, Maynard D, Denys H, Lambein K, Braems
G, et al: Bone marrow-derived mesenchymal stem cells promote
colorectal cancer progression through paracrine neuregulin 1/HER3
signalling. Gut. 62:550–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
